Evidence map›Paper›PMID 30366519›Full record

ReviewAdvances in immunology2018

The Fly Way of Antiviral Resistance and Disease Tolerance.

Jonathan Chow, Jonathan C Kagan

Abstract readReview
In one paragraph

Review in Advances in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. RNA modifications in insects.Frontiers in insect science · 2024
    Review
  5. Frontiers in microbiology · 2024
    Article
  6. The lncRNA-mediated ceRNA network ofFrontiers in physiology · 2023
    Article
  7. Article
  8. Frontiers in microbiology · 2022
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jonathan ChowDivision of Gastroenterology, Harvard Medical School, Boston Children's Hospital, Boston, MA, United States.
Jonathan C KaganDivision of Gastroenterology, Harvard Medical School, Boston Children's Hospital, Boston, MA, United States. Electronic address: jonathan.kagan@childrens.harvard.edu.

Funding

STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WAYNE I LENCER · 1986 to 2026
$32.4M
Initiation and Regulation of Antiviral Innate ImmunityR01AI093589 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI KAGAN, JONATHAN C · 2011 to 2020
$4.4M
Defining the pathways activated by Toll-like Receptors to stimulate immunityR37AI116550 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI JONATHAN C KAGAN · 2021 to 2026
$3.3M
Characterization of the myddosome, a protein complex that controls TLR signalingR01AI116550 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI KAGAN, JONATHAN C · 2017 to 2020
$1.8M
Initiation and Regulation of Antiviral Innate ImmunityR56AI093589 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI KAGAN, JONATHAN C · 2021 to 2021
$531k
NIAID NIH HHS R01 AI093589NIAID NIH HHS R01 AI116550NIAID NIH HHS R37 AI116550NIAID NIH HHS R56 AI093589NIDDK NIH HHS P30 DK034854
6 · The paper itself

Abstract

Like humans, insects face the threat of viral infection. Despite having repercussions on human health and disease, knowledge gaps exist for how insects cope with viral pathogens. Drosophila melanogaster serves as an ideal insect model due to its genetic tractability. When encountering a pathogen, two major approaches to fight disease are resistance strategies and tolerance strategies. Disease resistance strategies promote the health of the infected host by reducing pathogen load. Multiple disease resistance mechanisms have been identified in Drosophila: RNA interference, Jak/STAT signaling, Toll signaling, IMD signaling, and autophagy. Disease tolerance mechanisms, in contrast, do not reduce pathogen load directly, but rather mitigate the stress and damage incurred by infection. The main benefit of tolerance mechanisms may therefore be to provide the host with time to engage antiviral resistance mechanisms that eliminate the threat. In this review, antiviral resistance mechanisms used by Drosophila will be described and compared to mammalian antiviral mechanisms. Disease tolerance will then be explained in a broader context as this is a burgeoning field of study.

Indexed as

Immunity, InnateAnimalsAntiviral AgentsAutophagyDisease ResistanceDrosophila melanogasterDrosophila ProteinsHumansImmune ToleranceJanus KinasesRNA InterferenceSignal TransductionSTAT Transcription FactorsToll-Like ReceptorsVirus DiseasesAntiviral AgentsDrosophila Proteinsimd protein, DrosophilaJanus KinasesSTAT Transcription FactorsToll-Like ReceptorsAntiviral resistanceAutophagyDisease toleranceDrosophilaIMDImmunityJak/STATRNAiToll

Identifiers

PMID30366519
PMCPMC6698369

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.